KalVista Pharmaceuticals, Inc.
KALV
$11.85
$0.100.85%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.87% | 4.86% | 234.99% | 31.60% | 41.39% |
| Total Receivables | -47.14% | 39.28% | -60.30% | -39.30% | -40.24% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 56.50% | 34.27% | -1.68% | -13.83% | -15.73% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.44% | 7.09% | 156.82% | 18.40% | 27.89% |
|
|
|||||
| Total Current Assets | 7.44% | 7.09% | 156.82% | 18.40% | 27.89% |
| Net Property, Plant & Equipment | -9.13% | -17.66% | -23.46% | -19.37% | -23.35% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 292.89% | 173.02% | 249.37% | 96.44% | 470.75% |
| Total Assets | 7.65% | 6.53% | 142.17% | 15.92% | 24.86% |
|
|
|||||
| Total Accounts Payable | -45.62% | -46.38% | 88.84% | 6.17% | 113.28% |
| Total Accrued Expenses | 83.21% | 120.25% | 23.42% | 31.79% | 30.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 67.88% | 51.84% | 21.65% | 33.89% | 12.66% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 71.23% | 98.04% | 33.91% | 24.86% | 58.58% |
|
|
|||||
| Total Current Liabilities | 71.23% | 98.04% | 33.91% | 24.86% | 58.58% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.43% | -28.01% | -30.67% | -28.58% | -27.34% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 537.67% | 439.10% | 415.53% | 10.46% | 30.49% |
|
|
|||||
| Common Stock & APIC | 10.88% | 10.88% | 44.75% | 34.08% | 34.31% |
| Retained Earnings | -39.81% | -39.05% | -41.37% | -39.49% | -38.48% |
| Treasury Stock & Other | -122.62% | -49.48% | 32.97% | 22.05% | 0.76% |
| Total Common Equity | -76.39% | -53.82% | 63.83% | 17.08% | 24.02% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -76.39% | -53.82% | 63.83% | 17.08% | 24.02% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -76.39% | -53.82% | 63.83% | 17.08% | 24.02% |
|
|
|||||